Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)
China
· Delayed Price · Currency is CNY 96.00
-3.69 (-3.70%)
At close: Apr 29, 2026
SHA:688198 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 13,224 | 14,740 | 14,977 | 17,008 | 17,502 | 24,524 | Upgrade
|
| Market Cap Growth | -10.41% | -1.58% | -11.94% | -2.82% | -28.63% | 228.95% | Upgrade
|
| Enterprise Value | 13,025 | 14,479 | 14,590 | 16,535 | 16,744 | 23,773 | Upgrade
|
| Last Close Price | 96.00 | 107.01 | 108.18 | 122.68 | 126.51 | 177.61 | Upgrade
|
| PE Ratio | 65.40 | 76.15 | 102.35 | 147.63 | 183.98 | 479.01 | Upgrade
|
| Forward PE | - | 104.25 | 104.25 | 104.25 | 104.25 | 238.22 | Upgrade
|
| PS Ratio | 19.93 | 23.77 | 29.84 | 45.89 | 59.30 | 97.39 | Upgrade
|
| PB Ratio | 9.75 | 11.23 | 11.98 | 14.31 | 15.92 | 24.82 | Upgrade
|
| P/TBV Ratio | 11.08 | 12.83 | 13.34 | 15.68 | 16.57 | 25.92 | Upgrade
|
| P/FCF Ratio | 239.30 | 239.31 | - | 1356.96 | 728.83 | 5741.55 | Upgrade
|
| P/OCF Ratio | 66.17 | 74.53 | 109.94 | 120.49 | 135.83 | 320.60 | Upgrade
|
| EV/Sales Ratio | 19.63 | 23.35 | 29.07 | 44.61 | 56.73 | 94.41 | Upgrade
|
| EV/EBITDA Ratio | 49.13 | 59.35 | 96.98 | 149.37 | 190.74 | 656.86 | Upgrade
|
| EV/EBIT Ratio | 58.84 | 70.35 | 111.26 | 166.17 | 203.78 | 787.92 | Upgrade
|
| EV/FCF Ratio | 235.70 | 235.06 | - | 1319.18 | 697.26 | 5565.71 | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.07 | 0.01 | 0.01 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.26 | 0.38 | 0.06 | 0.11 | 0.02 | 0.04 | Upgrade
|
| Debt / FCF Ratio | 1.23 | 1.52 | - | 0.98 | 0.06 | 0.39 | Upgrade
|
| Net Debt / Equity Ratio | -0.14 | -0.17 | -0.29 | -0.44 | -0.56 | -0.78 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.71 | -0.94 | -2.39 | -4.73 | -6.97 | -21.29 | Upgrade
|
| Net Debt / FCF Ratio | -3.39 | -3.73 | 13.33 | -41.75 | -25.46 | -180.42 | Upgrade
|
| Asset Turnover | 0.43 | 0.41 | 0.36 | 0.30 | 0.27 | 0.27 | Upgrade
|
| Inventory Turnover | 1.00 | 1.11 | 1.34 | 1.13 | 1.17 | 1.55 | Upgrade
|
| Quick Ratio | 3.02 | 2.38 | 4.45 | 7.75 | 10.66 | 22.23 | Upgrade
|
| Current Ratio | 5.40 | 3.98 | 5.17 | 8.43 | 11.45 | 23.31 | Upgrade
|
| Return on Equity (ROE) | 14.61% | 14.02% | 10.84% | 9.56% | 9.04% | 5.62% | Upgrade
|
| Return on Assets (ROA) | 9.02% | 8.42% | 5.94% | 4.96% | 4.65% | 1.98% | Upgrade
|
| Return on Invested Capital (ROIC) | 17.15% | 18.18% | 14.78% | 15.73% | 20.72% | 20.59% | Upgrade
|
| Return on Capital Employed (ROCE) | 15.40% | 14.70% | 10.00% | 8.00% | 7.40% | 3.00% | Upgrade
|
| Earnings Yield | 1.53% | 1.31% | 0.98% | 0.68% | 0.54% | 0.21% | Upgrade
|
| FCF Yield | 0.42% | 0.42% | -0.18% | 0.07% | 0.14% | 0.02% | Upgrade
|
| Dividend Yield | 0.80% | - | 0.74% | 0.65% | 0.40% | 0.20% | Upgrade
|
| Payout Ratio | 55.02% | 57.26% | 74.67% | 58.88% | 50.69% | 37.51% | Upgrade
|
| Buyback Yield / Dilution | -1.44% | -0.39% | 0.29% | -0.92% | -0.86% | -0.44% | Upgrade
|
| Total Shareholder Return | -0.64% | -0.39% | 1.03% | -0.27% | -0.47% | -0.24% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.